Literature DB >> 3219380

Antagonism of estrogen-induced prolactin release by progesterone.

D W Brann1, I M Rao, V B Mahesh.   

Abstract

Previous work from our laboratory has shown that during the process of nuclear occupancy of the progesterone receptor complex (1-2 h), nuclear estradiol receptors of the anterior pituitary are depleted. The purpose of this study was to determine whether the depletion of nuclear estradiol receptors by progesterone had functional biological significance. The ovariectomized (26 days of age) immature rat was used as the model for analysis of this question. The ability of estradiol to release prolactin from the anterior pituitary was the function chosen to determine the biological significance of the progesterone and estradiol interactions. In response to estradiol exposure (2 micrograms/rat), prolactin release reached peak values from 8 h to 12 h and returned to control levels by 24 h. A second injection of estradiol 13 h after the initial injection stimulated a second increase in serum prolactin at 25 h. This model of two injections of estradiol 13 h apart served to provide adequate levels of anterior pituitary progesterone receptors and elevated serum prolactin levels upon which superimposed progestin modulation could be examined. A single injection of progesterone (0.8 mg/kg BW) 1 h before the second estradiol injection blocked the increase in serum prolactin. This action was a receptor-mediated event because progesterone had no effect without estrogen priming or when the progesterone antagonist RU486 was used. Finally, when the interval between the progesterone and second estradiol injection was extended to 4 h, a time period when progesterone does not deplete pituitary nuclear estrogen receptors, the estrogen-induced increase in serum prolactin was not blocked.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3219380     DOI: 10.1095/biolreprod39.5.1067

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  7 in total

1.  In vivo antiestrogenic activity of mifepristone in the rat.

Authors:  J Nedvídková; V Schreiber; L Stárka
Journal:  J Endocrinol Invest       Date:  1997-04       Impact factor: 4.256

2.  Progesterone antagonizes the permissive action of estradiol on tumor necrosis factor-alpha-induced apoptosis of anterior pituitary cells.

Authors:  M Candolfi; G Jaita; V Zaldivar; S Zárate; L Ferrari; D Pisera; M G Castro; A Seilicovich
Journal:  Endocrinology       Date:  2004-11-04       Impact factor: 4.736

Review 3.  Hirsutism, virilism, polycystic ovarian disease, and the steroid-gonadotropin-feedback system: a career retrospective.

Authors:  Virendra B Mahesh
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-10-25       Impact factor: 4.310

4.  Refinement of a protocol for the induction of lactation in nonpregnant nonhuman primates by using exogenous hormone treatment.

Authors:  Shannon D Smith; Joshua D Amos; Krista N Beck; Lisa M Colvin; Kelly S Franke; Brooke E Liebl; Sallie R Permar
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-11       Impact factor: 1.232

Review 5.  Estrogen-growth factor interactions and their contributions to neurological disorders.

Authors:  Helen E Scharfman; Neil J MacLusky
Journal:  Headache       Date:  2008-07       Impact factor: 5.887

6.  Pituitary Sex Steroid Receptors: Localization and Function.

Authors:  Lucia Stefaneanu
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

7.  Estrogens induce expression of membrane-associated estrogen receptor α isoforms in lactotropes.

Authors:  Sandra Zárate; Gabriela Jaita; Jimena Ferraris; Guadalupe Eijo; María L Magri; Daniel Pisera; Adriana Seilicovich
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.